Aims and Scope
BioImpacts (BI) is a peer-reviewed multidisciplinary international journal, covering original research articles, reviews, commentaries, hypotheses, methodologies, and visions/reflections dealing with all aspects of pharmaceutical and biomedical researches at molecular, cellular, functional, and translational dimensions, including:
Interdisciplinary, multidisciplinary, and transdisciplinary advanced science and technologies towards translational medicine
Pharmaceutical nanobiotechnology (nanobiomedicines, theranostics/diapeutics, hybrid nanosystems such as bispecific antibodies and aptamers)
Advanced targeted nanobiosensing and imaging
Integration of advanced approaches (genomics, proteomics, cytomics, and metabolomics) technologies with biomedical/pharmaceutical sciences
Biomaterials and natural products impacts in biomedical sciences - works that assess the natural products in life sciences must also include mechanism(s) of the action of natural products
Cell therapy and gene therapy
Regenerative medicines (tissue engineering, stem cells, bioengineering)
Translation of the basic biomedical/pharmaceutical sciences into in vivo applications
Mathematical modeling and bioinformatics in medical and pharmaceutical sciences
Clinical trials and reports on advanced pharmaceuticals and biologicals
Therapeutic biomacromolecules and biologicals (mAbs, vaccines)
Advanced nanobioconjugates
Lab-on-a-chip; Cell-on-a-chip; Tissue/organ-on-a-chip
Researches related to the philosophy of pharmaceutical/medical sciences